Open AccessEfficacy and safety of Infliximab for steroid‑resistant immune‑related adverse events: A retrospective study
Author(s) -
Yukio Kadokawa,
Mari Takagi,
Tomoe Yoshida,
Akitoshi Tatsumi,
Keiko Fujita,
Tomio Inoue,
Shuichi Ohe,
Yasutomo Nakai,
Sachiko Yamamoto,
Tomoyuki Otsuka,
Ryu Ishihara,
Taiki Isei,
Toru Kumagai,
Kazuo Nishimura,
Fumio Imamura
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2227
Subject(s) - medicine , infliximab , adverse effect , common terminology criteria for adverse events , cancer , gastroenterology , immunology , surgery , tumor necrosis factor alpha